Literature DB >> 11129412

Functions of the VEGF/VEGF receptor system in the vascular system.

G Breier1.   

Abstract

The vascular endothelial growth factor (VEGF)/VEGF receptor system plays a central regulatory role in physiological and pathological angiogenesis. During embryogenesis, the VEGF/VEGF receptor system is critically involved in the formation of the vascular system by regulating both the growth and the survival of blood vessels. In the vasculature of the adult organism, the high-affinity signaling VEGF receptor-2 (VEGFR-2) is downregulated but is reinduced during transient phases of physiological angiogenesis. Moreover, a variety of pathological conditions are associated with the upregulation of VEGF and the VEGF receptors. VEGF stimulates angiogenesis and the survival of endothelial cells in tumors, thereby enabling tumor expansion and metastasis. VEGF is also upregulated in ischemic diseases, such as coronary heart disease or stroke, and is thought to stimulate the--often insufficient--compensatory formation of blood vessels. The implication of VEGF in these pathological processes has opened up promising new therapeutic strategies. In malignancies, attempts are made to inhibit VEGF-mediated signaling and angiogenesis. In ischemic disease, the exogenous application of VEGF may enhance the formation of collaterals. However, considering the complexity of the regulatory pathways involved in the formation of new blood vessels under physiological conditions, a treatment relying on VEGF as the sole angiogenic factor may be insufficient, and the combination with other factors may improve the functionality of newly formed blood vessels and the efficacy of therapeutic angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129412     DOI: 10.1055/s-2000-13212

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  10 in total

1.  Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment.

Authors:  Sung Su An; Hong Lian Jin; Keung Nyun Kim; Dong Seok Kim; Joon Cho; Meng-Lu Liu; Jin Soo Oh; Do Heum Yoon; Min Hyung Lee; Yoon Ha
Journal:  Childs Nerv Syst       Date:  2010-03       Impact factor: 1.475

2.  Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.

Authors:  Julie Hanson; Jacquelyn Gorman; Jennifer Reese; Gail Fraizer
Journal:  Front Biosci       Date:  2007-01-01

3.  The determination of VEGF and MVD, among patients with primary breast cancer.

Authors:  Anna Thielemann; Zygmunt Kopczyński; Violetta Filas; Jan Breborowicz; Sylwia Grodecka-Gazdecka; Aleksandra Baszczuk
Journal:  Pathol Oncol Res       Date:  2008-04-09       Impact factor: 3.201

Review 4.  Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling.

Authors:  Debabrata Mukhopadhyay; Huiyan Zeng; Resham Bhattacharya
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

5.  Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?

Authors:  Ana A Baburamani; C Joakim Ek; David W Walker; Margie Castillo-Melendez
Journal:  Front Physiol       Date:  2012-11-09       Impact factor: 4.566

6.  The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium.

Authors:  Thomas Brock; Elisabeth Boudriot; Anke Klawitter; Marianne Großer; Trang T P Nguyen; Sindy Giebe; Erik Klapproth; Achim Temme; Ali El-Armouche; Georg Breier
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

7.  Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart.

Authors:  Munira Xaymardan; Jingang Zheng; Inga Duignan; Andrew Chin; Jacquelyne M Holm; Victoria L T Ballard; Jay M Edelberg
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

8.  Gestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamine.

Authors:  Shashi P Singh; Sravanthi Gundavarapu; Kevin R Smith; Hitendra S Chand; Ali Imran Saeed; Neerad C Mishra; Julie Hutt; Edward G Barrett; Matloob Husain; Kevin S Harrod; Raymond J Langley; Mohan L Sopori
Journal:  Environ Health Perspect       Date:  2013-06-11       Impact factor: 9.031

9.  Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.

Authors:  Adam J Mead; Wen Hao Neo; Nikolaos Barkas; Sahoko Matsuoka; Alice Giustacchini; Raffaella Facchini; Supat Thongjuea; Lauren Jamieson; Christopher A G Booth; Nicholas Fordham; Cristina Di Genua; Deborah Atkinson; Onima Chowdhury; Emmanouela Repapi; Nicki Gray; Shabnam Kharazi; Sally-Ann Clark; Tiphaine Bouriez; Petter Woll; Toshio Suda; Claus Nerlov; Sten Eirik W Jacobsen
Journal:  J Exp Med       Date:  2017-06-21       Impact factor: 14.307

Review 10.  Review on the Lymphatic Vessels in the Dental Pulp.

Authors:  Kamila Wiśniewska; Zbigniew Rybak; Maria Szymonowicz; Piotr Kuropka; Maciej Dobrzyński
Journal:  Biology (Basel)       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.